Opinion: My patient would rather take a peptide than a statin. That reveals an uncomfortable truth in medicine
Stat News • 4/3/2026
Summary
Vikas Patel discusses the preference of a patient for a peptide over a statin, highlighting a trend where the volume of evidence supporting a therapy is inversely correlated with public trust in it.
Advertisement
Lindy Score Breakdown (V4.2)
10h
Age
1
Sources
from cluster
14
Hours Since Seen
Final Score11/100
CategoryAntiLindy
StatusActive
Recency Multiplier82% (0.5^14/48)
Hero EligibleYes
Score BreakdownRisk 70
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: Breaking news - too recent to assess longevity
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: Pharmalittle: We’re reading about FDA view on peptide compounding, Iran war hurting trial recruitment, and more
Stat News • 2 days ago
STAT+: Insilico Medicine CEO on how best to use AI in drug development
Stat News • 2 days ago
Opinion: Medical misinformation wins when patients can’t see their doctors
Stat News • 1 day ago
Opinion: Subscription pricing could expand access to HIV prevention breakthrough while controlling costs
Stat News • Today
Opinion: Medical marijuana should not be recommended for PTSD, anxiety, or depression
Stat News • 2 days ago
Opinion: Medicare is restricting care for 1 million Americans based on a faulty assumption. Congress must intervene
Stat News • 2 days ago
Opinion: STAT+: Cardiology’s finally prioritizing prevention — but what will it look like?
Stat News • 1 day ago
Supreme Court conversion therapy decision could ripple through medicine
Stat News • Today
STAT+: ‘Takeover Tuesday’ saves biotech’s quarter
Stat News • 1 day ago
STAT+: Proposed ‘preclinical obesity’ diagnosis ignites global debate among experts
Stat News • 1 day ago
Anti-Lindy Similar stories
STAT+: Pharmalittle: We’re reading about Trump pushing drug pricing policy, Chinese biotech licensing, and more
Stat News • 4 days ago
STAT+: FDA approves Denali Therapeutics drug for Hunter syndrome
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about a Merck acquisition, the rise of former Loxo execs at Lilly, and more
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more
Stat News • 1 week ago